Quote:
Originally Posted by Logseman
Is it just me who notices certain parallels between the two cost-spiraling industries? Doctors/Teachers do not get to choose what meds/books are to be purchased by patients/students but it is a central body above them, so the middlemen go directly to lobby the central body in order to get their texts selected, and since the hospitals/universities are isolated from the effects of the choices, there is no cost-saving incentive but obscure settlements between big pharma/big publishers and the central bodies.
|
I think that this is a very good comparison. We can extend it some more by saying that the next version of the product is often a dubious improvement over the old version. Being new is the important characteristic of the product.